IGF1R signaling can stimulate cell proliferation and protect cell from stress in triple negative breast cancer and is regarded as a therapeutic target for treatment (Klinakis et al., 2009; Castano et al., 2013; Obr et al., 2018). This evidence concerns the gene IGF1R and triple-negative breast carcinoma.